Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada
- PMID: 31132871
- DOI: 10.1177/1203475419852048
Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada
Abstract
Background: We recently reported a steady increase in the incidence and mortality of cutaneous malignant melanoma (CMM) in Canada during 1992-2010.
Objectives: The objective of this article is to examine the distribution of Canadian CMM patients at the level of provinces, cities, and forward sortation area (FSA) postal codes.
Methods: Using 3 Canadian population-based registries, we conducted an in-depth examination of the incidence and mortality trends for 72 565 Canadian CMM patients over the period 1992-2010.
Results: We found that among 20- to 39-year-olds, the incidence of CMM in women (7.17 per 100 000 individuals) was significantly higher than in men (4.60 per 100 000 individuals per year). Women age 80 years and older had an incidence of CMM (58.46 cases per 100 000 women per year) more than 4 times greater than the national average (12.29 cases per 100 000 population per year) and a corresponding high mortality rate (20.18 deaths per 100 000 women per year), when compared with the Canadian melanoma mortality of 2.4 deaths per 100 000 per year. In other age groups men had higher incidence and corresponding melanoma mortality rates. We also studied CMM incidence by province, city, and FSA postal codes and identified several high-incidence communities that were located near the coast/waterfronts. In addition, plotting latitude measures for cities and FSAs vs CMM incidence rate confirmed the inverse relationship between geographical latitude and incidence of melanoma in Canada (slope = -0.22 ± 0.05).
Conclusions: This research may help develop sex-, age- and geographic region-specific recommendations to decrease the future burden of CMM in Canada.
Keywords: CMM; cutaneous malignant melanoma; epidemiology in Canada; incidence in Canada; mortality in Canada; patient clusters; risk factors; sun-exposure practices.
Similar articles
-
Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.J Am Acad Dermatol. 2019 Feb;80(2):448-459. doi: 10.1016/j.jaad.2018.07.041. Epub 2018 Aug 6. J Am Acad Dermatol. 2019. PMID: 30092328
-
Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.Pigment Cell Res. 1992;Suppl 2:285-94. doi: 10.1111/j.1600-0749.1990.tb00387.x. Pigment Cell Res. 1992. PMID: 1409431
-
Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.Cancer. 2017 Sep 15;123(18):3550-3567. doi: 10.1002/cncr.30758. Epub 2017 May 10. Cancer. 2017. PMID: 28493286
-
Cutaneous malignant melanoma: epidemiological considerations.Semin Surg Oncol. 1992 Nov-Dec;8(6):345-52. doi: 10.1002/ssu.2980080603. Semin Surg Oncol. 1992. PMID: 1439443 Review.
-
Socioeconomic status and cutaneous malignant melanoma in Northern Europe.Br J Dermatol. 2014 Apr;170(4):787-93. doi: 10.1111/bjd.12800. Br J Dermatol. 2014. PMID: 24359255 Review.
Cited by
-
Recurrent melanoma development in a Caucasian female with CDKN2A+ mutation and FAMMM syndrome: A case report.SAGE Open Med Case Rep. 2020 Sep 2;8:2050313X20936034. doi: 10.1177/2050313X20936034. eCollection 2020. SAGE Open Med Case Rep. 2020. PMID: 32953120 Free PMC article.
-
Mortality of Malignant Melanoma in Central Serbia, in the Period 1999-2015.Dermatol Pract Concept. 2023 Jan 1;13(1):e2023008. doi: 10.5826/dpc.1301a8. Dermatol Pract Concept. 2023. PMID: 36892369 Free PMC article.
-
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study.J Immunother Cancer. 2023 Jun;11(6):e006747. doi: 10.1136/jitc-2023-006747. J Immunother Cancer. 2023. PMID: 37286303 Free PMC article. Clinical Trial.
-
Gene-Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk.Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1599-1607. doi: 10.1158/1055-9965.EPI-23-0545. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37642678 Free PMC article.
-
A Review of Epidemiology and Cancer Biology of Malignant Melanoma.Cureus. 2021 May 18;13(5):e15087. doi: 10.7759/cureus.15087. Cureus. 2021. PMID: 34155457 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical